p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage

Summary

This is multicenter, open-label, randomized, active-controled, phase IV study of local direct intra-tumor injection of rAd-p53 monotherapy, with concurrent chemotherapy , with concurrent radiotherapy, or combination with surgery for treatment of head and neck malignant tumors in advanced stage .

Timeline

Start

2009-05

Primary completion

2012-06

Completion

2013-06

Drugs

Indications